WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.
The retail recall is for all unexpired albuterol sulfate inhalation aerosol made by Catalent Pharma Solutions for Perrigo Pharmaceutical Company. The inhalers are used to treat asthma and other airway/lung conditions, such as chronic obstructive pulmonary disease.
Patients should continue to use the Perrigo inhaler they have, as needed and as directed by a doctor, the FDA said.
Some of the recalled inhalers stop working after several uses. If their rescue albuterol inhaler malfunctions and doesn’t relieve symptoms in an emergency situation, patients should immediately seek emergency care if needed, the FDA advised.
It recommended that patients have extra inhalers or an alternative treatment available in case of inhaler malfunction.
For more information, patients should talk with their health care provider or pharmacist, the FDA said.
Copyright © 2019 HealthDay. All rights reserved.
- Optimize Your Immune System — Even in a Pandemic - October 20, 2020
- Health Highlights: Oct. 19, 2020 - October 20, 2020
- Survey: Only Half of Organizations Believe They Can Stop Cyber Attacks - October 20, 2020
- मुख्यमंत्री श्री चौहान से मिले सतना जिले के युवा साइकिल यात्री - October 20, 2020
- CGHS: केंद्रीय कर्मियों को जिंदगीभर नहीं देना पड़ता है अस्पताल का खर्चा, जानें किन लोगों को मिलती है ये सुविधा - October 20, 2020
- Canada tops 200,000 COVID-19 cases - October 20, 2020
- Introducing The Planmeca Promax 3D at O’Neill Orthodontics - October 20, 2020
- Staying Social Can Boost Healthy ‘Gray Matter’ in Aging Brains - October 20, 2020
- Athletes Advance to Final Phase of The Next Olympic Hopeful - October 20, 2020
- Panacea Biotec Hiring BSc MSc for QA Executive Sr Executive QMS - October 20, 2020